Tỷ suất cổ tức của ERNAW là bao nhiêu?

Ernexa Therapeutics Inc. Warrants có tỷ suất cổ tức 0.00%.

Bây giờ có nên mua cổ phiếu ERNAW không?

Điểm AI Timing của ERNAW là 0/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu ERNAW (NASDAQ) | Ernexa Therapeutics Inc.

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-06 | FS: -)

ERNAW AI Analysis Summary

Our AI summary for ERNAW: Ernexa Therapeutics Inc. Warrants (NASDAQ). The stock currently trades at a P/E of 0.00, a dividend yield of 0.00%. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ERNAW

Ernexa Therapeutics Inc. Warrants

US:NASDAQ STOCK News 99

USD 0.04

0.00 (4.18%) Day Change

Watchlist Portfolio Compare Chart

0.00%

Div Yield

ERNEXA THERAPEUTICS INC. WARRANTS
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.04 Price 0.00 (4.18%) Day Change	NEWS SCORE: 99

Not enough data to analyze.

Loading chart...

N/A

QUALITY

Signal: N/A

Signal Description: N/A

Reason: N/A

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.04
PBV / Sector	0.01 / N/A GREAT
Earning Per Share	N/A

PE / Sector	N/A / N/A
PEG or PE/Growth / Sector	N/A / N/A
Average 1M Daily Value	795.039525000000
Average 1W Daily Value	341.483940000000

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / N/A
NPM Average (%) / Sector	N/A / N/A
NPM Change Average (%) / Sector	N/A / N/A
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	N/A / N/A
ROA Average (%) / Sector	N/A / N/A
ROA Change Average (%) / Sector	N/A / N/A
ROE (%) / Sector	N/A / N/A
ROE Average (%) / Sector	N/A / N/A
ROE Change Average (%) / Sector	N/A / N/A
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

Chi tiết đăng ký

Analyze Date
Symbol	ERNAW
Name	ERNEXA THERAPEUTICS INC. WARRANTS
Sector	N/A
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	0.05 / N/A

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1035 Cambridge Street, Cambridge, MA, United States, 02141

Phone: 617 798 6700

Website: https://www.ernexatx.com

Sector: -

Description: Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.